Sign in
4

Changes in Ownership

PharmaCyte Biotech, Inc. Filed Acc 0001683168-25-009114

CEO and President gave up 258,750 shares (to pay taxes)

  • CEO and President acquired 575,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Silverman Joshua · CEO and President

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2025-12-12 Grant or award : show line 1 in the form +575,000 575,000 D
2025-12-12 Shares withheld for taxes : show line 2 in the form −258,750 $1.02 $263,925 316,250 D
Loading xslF345X05/ownership.xml…